An Open-Label Study to Determine Safety , Tolerability, and Efficacy of Oral Lacosamide in Children With Epilepsy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00938912
Recruitment Status : Enrolling by invitation
First Posted : July 14, 2009
Last Update Posted : December 7, 2018
Information provided by (Responsible Party):
UCB Pharma

No Study Results Posted on for this Study
  Recruitment Status : Enrolling by invitation
  Estimated Primary Completion Date : June 2022
  Estimated Study Completion Date : July 2022